Evolution of Minimally Invasive Mitral Valve Repair: 30-Year Experience From a High-Volume Center

Jagdip Kang1, Mateo Marin-Cuartas1, Philipp Kiefer1

  • 1University Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany.

Abstract

Insights

Minimally invasive mitral valve repair (MVr) outcomes have significantly improved over decades. Both isolated MVr and combined tricuspid valve (TV) surgery show enhanced long-term survival, demonstrating the procedure

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Cardiac Surgery
  • Valvular Heart Disease

Background:

  • Minimally invasive mitral valve repair (MVr) is a standard procedure, often combined with tricuspid valve (TV) surgery.
  • Limited evidence exists on the long-term outcomes and their evolution over time for these combined procedures.
  • This study investigates improvements in outcomes for minimally invasive MVr, both isolated and with concomitant TV surgery, over several decades.

Purpose of the Study:

  • To evaluate the long-term survival trends following minimally invasive mitral valve repair (MVr).
  • To assess the evolution of outcomes for minimally invasive MVr performed with or without concomitant tricuspid valve (TV) surgery.
  • To determine if surgical outcomes have improved over different time periods.

Main Methods:

  • Retrospective analysis of 5559 patients undergoing minimally invasive MVr between 1996 and 2023.
  • Patients were categorized into five surgical periods from 1996-2001 to 2020-2023.
  • Primary outcome was 10-year survival; subanalysis included patients with concomitant TV surgery.

Main Results:

  • 30-day mortality decreased from 1.1% in 1996-2001 to 0.3% in 2020-2023.
  • 10-year survival improved from 68.1% (1996-2001) to 83.7% (2014-2019).
  • For concomitant TV surgery, 1-year and 10-year survival rates significantly improved across periods.

Conclusions:

  • Minimally invasive MVr, alone or with TV surgery, is a safe and reproducible approach.
  • The procedure is associated with low complication rates and infrequent conversion to sternotomy.
  • Excellent early and long-term survival rates have been achieved and improved over time.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
220
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
253
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
386
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
351
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
371
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
380